Lineage Cell Therapeutics, Inc.: accounts_payable
| Value | {"amount": 2202410, "concept": "us-gaap:AccountsPayableCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2013-09-30) |
| Status | current |
| Entity | Lineage Cell Therapeutics, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T08:43:14.373961+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/751ee06b-9d3c-4cb2-9288-f4e2af5cd839
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001140361-13-041885 · Open the official SEC filing →Retrieved: 2026-08-19T08:43:14.373961+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000876343/accounts-payable/2013-09-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/751ee06b-9d3c-4cb2-9288-f4e2af5cd839
History
- no predecessors — first report